Results 281 to 290 of about 883,694 (328)

Stage E Cardiogenic Shock: Hold 'Em, Fold 'Em, or Double Down? [PDF]

J Soc Cardiovasc Angiogr Interv
Truesdell AG, Mehta A, Vavilin I.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Extracorporeal Life Support in Infarct-Related Cardiogenic Shock.

New England Journal of Medicine, 2023
BACKGROUND Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality.
H. Thiele, U. Zeymer, I. Akin, M. Behnes, T. Rassaf, A. Mahabadi, R. Lehmann, I. Eitel, T. Graf, Tim Seidler, Andreas Schuster, C. Skurk, D. Duerschmied, P. Clemmensen, M. Hennersdorf, S. Fichtlscherer, I. Voigt, M. Seyfarth, Stefan John, S. Ewen, A. Linke, E. Tigges, P. Nordbeck, Leonhard Bruch, C. Jung, Jutta Franz, P. Lauten, Tomaz Goslar, H. Feistritzer, J. Pöss, Eva Kirchhof, T. Ouarrak, Steffen Schneider, S. Desch, A. Freund   +34 more
semanticscholar   +1 more source

Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)

Circulation, 2023
The Shock Academic Research Consortium is a multi-stakeholder group, including representatives from the US Food and Drug Administration and other government agencies, industry, and payers, convened to develop pragmatic consensus definitions useful for ...
R. Waksman, M. Pahuja, Sean van Diepen, A. Proudfoot, D. Morrow, Ernest Spitzer, Graham Nichol, M. Weisfeldt, Mauro Moscucci, P. Lawler, Alexandre Mebazaa, E. Fan, Neal W. Dickert, Marc D. Samsky, R. Kormos, Ileana L. Piña, Bram D. Zuckerman, Andrew Farb, J. Sapirstein, Charles Simonton, N. E. West, Abdulla A. Damluji, Ian C. Gilchrist, U. Zeymer, H. Thiele, D. Cutlip, Mitchell W. Krucoff, William T. Abraham   +27 more
semanticscholar   +1 more source

Prognostic value of Intermountain Risk Score for short- and long-term mortality in patients with cardiogenic shock

Coronary Artery Disease, 2023
Background There is a lack of current research examining the predictive value of the Intermountain Risk Score (IMRS) in patients with ST-segment elevation myocardial infarction (STEMI) caused by cardiogenic shock.
Hayıroğlu Mert İlker, Saylik Faysal, Yumurtaş Ahmet Çağdaş, Selçuk Murat, Çinar Tufan   +4 more
semanticscholar   +1 more source

Advances in the Management of Cardiogenic Shock

Critical Care Medicine, 2023
OBJECTIVES: To review a contemporary approach to the management of patients with cardiogenic shock (CS). DATA SOURCES: We reviewed salient medical literature regarding CS.
J. Jentzer, J. Pöss, H. Schaubroeck, D. Morrow, S. Hollenberg, A. Mebazaa   +5 more
semanticscholar   +1 more source

Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock

European Journal of Heart Failure, 2022
Cardiogenic shock (CS) with variable systemic inflammation may be responsible for patient heterogeneity and the exceedingly high mortality rate. Cardiovascular events have been associated with clonal haematopoiesis (CH) where specific gene mutations in ...
F. Scolari, Sagi Abelson, D. Brahmbhatt, Jessie J. F. Medeiros, C. Fan, Nicole L. Fung, Vesna Mihajlovic, M. Anker, Madison Otsuki, P. Lawler, H. Ross, A. Luk, S. Anker, J. Dick, F. Billia   +14 more
semanticscholar   +1 more source

Cardiogenic shock

Current Treatment Options in Cardiovascular Medicine, 2000
In the setting of acute myocardial infarction, the timely recognition and treatment of cardiogenic shock are essential in reducing the incidence of death. Patients with cardiogenic shock should be treated aggressively with a combination of pharmacologic agents and mechanical support devices to achieve stabilization. Once stabilization has been achieved,
Richard W. Smalling, Michael Rihner
openaire   +3 more sources

Cardiogenic Shock

Hospital Practice, 2010
The syndrome of cardiogenic shock (CS) comprises a constellation of symptoms and signs that define a subset of patients with inadequate tissue perfusion secondary to myocardial dysfunction. Careful attention to and rapid identification of patients at risk for the development of CS and those with impending CS by both hospitalists and subspecialists will
Nitasha, Sarswat, Steven M, Hollenberg
openaire   +5 more sources

Cardiogenic Shock

Emergency Medicine Clinics of North America, 2015
Cardiogenic shock is the leading cause of morbidity and mortality in patients presenting with acute coronary syndrome. Although early reperfusion strategies are essential to the management of these critically ill patients, additional treatment plans are often needed to stabilize and treat the patient before reperfusion may be possible.
Joshua B, Moskovitz, Zachary D, Levy, Todd L, Slesinger   +2 more
openaire   +4 more sources